Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
121,543,157
-
Total 13F shares
-
28,751,331
-
Share change
-
+10,216,651
-
Total reported value
-
$80,790,000
-
Price per share
-
$2.81
-
Number of holders
-
31
-
Value change
-
+$28,742,730
-
Number of buys
-
23
-
Number of sells
-
8
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q2 2022
As of 30 Jun 2022 Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,751,331 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, TPG GP A, LLC, VR Adviser, LLC, MAI Capital Management, Rubric Capital Management LP, Fairmount Funds Management LLC, Altium Capital Management LP, Frazier Life Sciences Management, L.P., ARMISTICE CAPITAL, LLC, and EAM Investors, LLC.
This table shows 31 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.